88124-95-2Relevant articles and documents
ARYL, HETEROARYL, AND HETEROCYCLIC COMPOUNDS FOR TREATMENT OF MEDICAL DISORDERS
-
Paragraph 0595, (2017/03/14)
Compounds, methods of use, and processes for making inhibitors of complement Factor D comprising Formula I, or a pharmaceutically acceptable salt or composition thereof wherein R12 or R13 on the A group is an aryl, heteroaryl or heterocycle (R32) are provided. The inhibitors of Factor D described herein reduce the excessive activation of complement.
FLUORESCENT LABELED INHIBITORS
-
Sheet 10, (2015/09/28)
Provided herein are a series of fluorescently labeled phosphonate and phosphate compounds such as can be used for affinity probes to detect certain enzymes including lipases. Also provided are methods of making and using such compounds.
Siloxanes with pendent naphthalene diimides: Synthesis and fluorescence quenching
Ganesan, Palaniswamy,Van Lagen, Barend,Marcelis, Antonius T. M.,Sudholter, Ernst J. R.,Zuilhof, Han
, p. 2296 - 2300 (2008/02/05)
Cyclic siloxanes with pendent naphthalene diimide groups were synthesized via hydrosilylation to form amorphous electron-accepting compounds. Photophysical measurements and >99.9% fluorescence quenching of well-known p-type polymers by the siloxanes demonstrate that these siloxanes form a new class of highly efficient n-type materials that provide some control over intermolecular interactions.
